行情

SRTS

SRTS

申舒斯医疗保健
NASDAQ

实时行情|Nasdaq Last Sale

3.510
-0.060
-1.68%
盘后: 3.590 +0.08 +2.28% 16:42 09/17 EDT
开盘
3.530
昨收
3.570
最高
3.670
最低
3.510
成交量
1.51万
成交额
--
52周最高
6.09
52周最低
2.320
市值
5,833.49万
市盈率(TTM)
-27.9459
分时
5日
1月
3月
1年
5年
Sensus Healthcare 将参加 HC Wainwright 第 23 届年度全球投资会议
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced that Joe Sardano, chairman and chief...
GlobeNewswire · 09/08 13:00
Sensus Healthcare 资本使用洞察的回报
According to Benzinga Pro data, during Q2, Sensus Healthcare (NASDAQ:SRTS) posted sales of $5.42 million. Earnings were up 74.98%, but Sensus Healthcare still reported an overall loss of $279.00 thousand.
Benzinga · 09/02 15:33
55 只股票在周五的午盘交易中移动
Gainers
Benzinga · 08/06 16:00
Sensus Healthcare, Inc. (SRTS) 报告第二季度亏损,高于收入预期
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 60.00% and 33.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/06 00:15
BRIEF-Sensus Healthcare Q2 Revenue Rose 358 Percent To $5.4 Million
reuters.com · 08/05 22:02
Sensus Healthcare 每股收益超过 0.04 美元,收入超过
Sensus Healthcare (NASDAQ:SRTS): Q2 GAAP EPS of -$0.02 beats by $0.04. Revenue of $5.4M (+357.6% Y/Y) beats by $1.12M. Press Release
Seekingalpha · 08/05 20:37
12 只医疗保健股在周四的盘后交易中移动
Gainers
Benzinga · 08/05 20:31
Sensus Healthcare 报告 2021 年第二季度财务业绩
Revenues of $5.4 million up 358% year-over-year, up 77% sequentially Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
GlobeNewswire · 08/05 20:05
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解SRTS最新的财务预测,通过SRTS每股收益,每股净资产,每股现金流等数据分析申舒斯医疗保健近期的经营情况,然后做出明智的投资选择。
分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测SRTS价格均价为7.04,最高价位7.75,最低价为6.00。
EPS
机构持股
总机构数: 29
机构持股: 161.81万
持股比例: 9.74%
总股本: 1,661.96万
类型机构数股数
增持
7
2.36万
建仓
1
3,000
减持
6
6.47万
平仓
3
3.53万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
+1.54%
医疗设备和用品
+0.65%
高管信息
Chairman/President/Chief Executive Officer/Co-Founder/Director
Joseph Sardano
Co-Founder/Executive Vice President
Stephen Cohen
Chief Financial Officer
Javier Rampolla
Chief Operating Officer
Nicolas Soro
Chief Technology Officer
Yonatan Vainer
Vice President/General Counsel
Michael Sardano
Director
Megan Cornish
Non-Executive Director
Anthony Petrelli
Non-Executive Independent Director
John Heinrich
Non-Executive Independent Director
William McCall
Non-Executive Independent Director
Samuel O'Rear
暂无数据
SRTS 简况
Sensus Healthcare Inc是一家医疗设备公司。该公司专注于为肿瘤性和非肿瘤性皮肤疾病提供非侵入性治疗。该公司使用一种称为表面放射治疗(SRT)的低能量x射线技术。该公司将SRT纳入其治疗设备组合:SRT-100、SRT-100 Plus和SRT-100 Vision。该公司的产品SRT-100是一种光子x射线低能表面放射治疗系统,为患者提供治疗非黑色素瘤皮肤癌的替代手术,包括基底细胞和鳞状细胞皮肤癌和其他皮肤状况,如瘢痕疙瘩。该公司的其他两款产品,如SRT-100 Plus和SRT-100 Vision,与SRT-100基本型号相比,为客户提供了更多选择。

微牛提供Sensus Healthcare Inc(NASDAQ-SRTS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的SRTS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易SRTS股票基本功能。